Skip to content

Natural History Study of MNGIE

Natural History Study of Mitochondrial Neurogastrointestinal Encephalomyopathy

Status
Suspended
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04245917
Enrollment
60
Registered
2020-01-29
Start date
2020-08-06
Completion date
2026-02-28
Last updated
2021-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mitochondrial Neurogastrointestinal Encephalomyopathy

Keywords

MNGIE

Brief summary

Non-interventional, prospective, multicenter, natural history study of patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)

Interventions

OTHERNon-interventional

Non-interventional natural history study

Sponsors

Entrada Therapeutics, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
5 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Has MNGIE

Exclusion criteria

* Substance abuser

Design outcomes

Primary

MeasureTime frameDescription
MNGIE Clinical Course5 yearsTo evaluate the clinical course of MNGIE patients

Countries

Turkey (Türkiye), United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026